4/A//SEC Filing
INTEGRATED PHARMACEUTICALS INC 4/A
Accession 0001072613-06-002603
CIK 0001265449operating
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 3:11 PM ET
Size
16.2 KB
Accession
0001072613-06-002603
Insider Transaction Report
Form 4/AAmended
SMITH DAVID H
Director10% Owner
Transactions
- Purchase
Common Stock Purchase Warrant
2006-12-21+483,333→ 828,333 total(indirect: See Footnotes 3 & 4)Exercise: $0.35From: 2006-12-21Exp: 2008-06-30→ Common Stock (483,333 underlying) - Purchase
Common Stock
2006-12-21$0.06/sh+996,667$59,800→ 3,711,702 total(indirect: See Footnote 2) - Purchase
Common Stock Purchase Warrant
2006-12-21+1,208,333→ 2,132,458 totalExercise: $0.35From: 2006-12-21Exp: 2008-06-30→ Common Stock (1,208,333 underlying) - Purchase
Common Stock
2005-03-14$1.74/sh+14,368$25,000→ 2,640,500 total - Purchase
Common Stock
2006-12-21$0.06/sh+2,416,667$145,000→ 6,128,368 total - Purchase
Common Stock
2006-05-22$0.24/sh+104,167$25,000→ 2,745,035 total
Footnotes (4)
- [F1]David Smith receives compensation for his service as a director at the rate of $25,000 per annum, payable in common stock of the issuer. In 2005, he received 14,368 shares of stock valued at $1.74 per share. In 2006, he received 104,167 shares of stock valued at $0.24 per share.
- [F2]The number of shares acquired indirectly includes 333,333 shares acquired by Fivex, LLC, 133,333 acquired by Tailwind V.C., LLC, 50,000 acquired by Interim Advantage Fund, LLC, 100,000 acquired by Contra V.C., LLC, 16,667 acquired by Cytra Corporation and 333,333 shares acquired by IAF Management, LLC Retirement Plan. The total number of shares owned indirectly includes: 140,000 shares owned by the Interim Advantage Fund, LLC; 283,333 shares owned by Tailwind V.C., LLC; 200,000 shares owned by Contra V.C., LLC; 633,333 shares owned by Fivex, LLC; and 66,667 shares owned by Cytra Corporation and 333,333 shares owned by IAF Management LLC Retirement Plan. The reporting person is a member and a manager of each of the LLCs and a controlling shareholder and director of Cytra Corporation. Mr. Smith disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- [F3]Warrants to purchase shares of common stock were acquired pursuant to a private placement of units in which purchasers obtained, for each $0.06 invested, one share of common stock and a warrant to acquire 50% of the number of shares of common stock acquired. The warrants are exercisable at $0.35 per share and expire on June 30, 2008. For reporting purposes, Mr. Smith ascribes all of the purchase price of the units to the common stock, and none to the warrants. The number of shares covered by the warrants reported as owned indirectly by Mr. Smith are as follow: Fivex, LLC, 166,667 shares; Tailwind V.C., LLC, 66,667; Interim Advantage Fund, LLC, 25,000 shares; Contra V.C., LLC, 50,000; and Cytra Corporation, 8,333 shares and IAF Management LLC Retirement Plan, 166,667 shares.
- [F4]Mr. Smith is also the direct and indirect owner of stock purchase warrants exercisable at $2.50 per share and expiring on December 31, 2006. The number of shares subject to warrants held directly is 924,125. The number of shares subject to warrants held indirectly is 345,000, consisting of: 45,000 warrants issued to the Interim Advantage Fund, LLC; 75,000 warrants issued to Tailwind V.C., LLC; 50,000 warrants issued to Contra V.C., LLC; 150,000 warrants issued to Fivex, LLC; and 25,000 warrants issued to Cytra Corporation. The reporting person is a member and a manager of each of the LLCs and a controlling shareholder and director of the corporation. Mr. Smith disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Documents
Issuer
INTEGRATED PHARMACEUTICALS INC
CIK 0001265449
Entity typeoperating
Related Parties
1- filerCIK 0001265449
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 3:11 PM ET
- Size
- 16.2 KB